Woodline Partners LP Regeneron Pharmaceuticals, Inc. Transaction History

Woodline Partners LP

  • $11 Billion
  • Q3 2024

A detailed history of Woodline Partners LP transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Woodline Partners LP holds 99,417 shares of REGN stock, worth $69.8 Million. This represents 0.95% of its overall portfolio holdings.

Number of Shares
99,417
Previous 181,897 45.34%
Holding current value
$69.8 Million
Previous $191 Million 45.33%
% of portfolio
0.95%
Previous 1.92%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$1024.09 - $1201.76 $84.5 Million - $99.1 Million
-82,480 Reduced 45.34%
99,417 $105 Million
Q2 2024

Aug 14, 2024
BUY
$883.2 - $1071.19 $9.98 Million - $12.1 Million
11,295 Added 6.62%
181,897 $191 Million
Q1 2024

May 15, 2024
BUY
$902.69 - $993.35 $462,177 - $508,595
512 Added 0.3%
170,602 $164 Million
Q4 2023

Feb 14, 2024
BUY
$775.18 - $881.7 $26 Million - $29.6 Million
33,518 Added 24.54%
170,090 $149 Million
Q3 2023

Nov 14, 2023
BUY
$692.45 - $844.37 $61.6 Million - $75.1 Million
88,910 Added 186.54%
136,572 $112 Million
Q2 2023

Aug 14, 2023
SELL
$700.03 - $830.35 $74.7 Million - $88.6 Million
-106,659 Reduced 69.12%
47,662 $34.2 Million
Q1 2023

May 15, 2023
SELL
$680.49 - $826.97 $3.52 Million - $4.28 Million
-5,172 Reduced 3.24%
154,321 $127 Million
Q4 2022

Feb 14, 2023
SELL
$705.89 - $766.39 $19.7 Million - $21.4 Million
-27,864 Reduced 14.87%
159,493 $115 Million
Q3 2022

Nov 14, 2022
BUY
$573.97 - $724.32 $77.2 Million - $97.5 Million
134,565 Added 254.9%
187,357 $129 Million
Q2 2022

Aug 15, 2022
SELL
$548.35 - $738.84 $28.9 Million - $38.9 Million
-52,702 Reduced 49.96%
52,792 $31.2 Million
Q1 2022

May 16, 2022
BUY
$595.12 - $698.43 $9.07 Million - $10.6 Million
15,248 Added 16.9%
105,494 $73.7 Million
Q4 2021

Feb 14, 2022
BUY
$543.48 - $670.97 $7.83 Million - $9.66 Million
14,400 Added 18.99%
90,246 $57 Million
Q3 2021

Nov 15, 2021
SELL
$574.03 - $680.96 $1.16 Million - $1.37 Million
-2,013 Reduced 2.59%
75,846 $45.9 Million
Q2 2021

Aug 16, 2021
SELL
$472.8 - $558.54 $51.1 Million - $60.3 Million
-108,040 Reduced 58.12%
77,859 $43.5 Million
Q1 2021

May 17, 2021
BUY
$446.73 - $548.2 $74 Million - $90.8 Million
165,695 Added 820.11%
185,899 $88 Million
Q4 2020

Feb 16, 2021
BUY
$478.3 - $607.98 $9.66 Million - $12.3 Million
20,204 New
20,204 $9.76 Million
Q3 2020

Nov 16, 2020
SELL
$544.75 - $658.21 $16.7 Million - $20.2 Million
-30,722 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$493.32 - $643.92 $1.6 Million - $2.09 Million
3,245 Added 11.81%
30,722 $19.2 Million
Q1 2020

May 15, 2020
BUY
$336.18 - $494.43 $9.24 Million - $13.6 Million
27,477 New
27,477 $13.4 Million

Others Institutions Holding REGN

# of Institutions
1,534
Shares Held
83.6M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $75.2B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Woodline Partners LP Portfolio

Follow Woodline Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email